PAI Pharmaceuticals

PAI Pharma, officially Pharmaceutical Associates, Inc., is a premier developer and manufacturer of liquid unit-dose pharmaceuticals based in Greenville, South Carolina. Established in 1968, the company has built a reputation as a leader in the generic liquid medication market, offering a portfolio of over 60 products. Their expertise spans various therapeutic categories, including pain management, central nervous system disorders, and gastrointestinal health. PAI Pharma is particularly recognized for its advanced unit-dose packaging, which provides healthcare facilities with safe and efficient medication delivery systems. In 2020, the company was acquired by Beach Point Capital Management, enabling further expansion of its 300,000-square-foot manufacturing facility and product pipeline.